Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fibroblast Growth Factor 23”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01312714
What this trial is testing

Vitamin D3 Supplementation in Dialysis Patients

Who this might be right for
End-Stage Renal Disease
Regional Hospital Holstebro 64
Not applicableStudy completedNCT02951442
What this trial is testing

Identification of Markers (Klotho-FGF23 Axis) as Determinant in the Evolution of Arterial Stiffness During the First Year of Renal Transplant

Who this might be right for
Renal Transplant
Hopital Foch 117
Post-approval studies (Phase 4)UnknownNCT02598635
What this trial is testing

Effects of Cholecalciferol on Osteoprotegerin Levels in Patients on Peritoneal Dialysis

Who this might be right for
Vitamin D DeficiencyVascular CalcificationRenal Insufficiency+1 more
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 58
Not applicableStudy completedNCT00843349
What this trial is testing

Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)

Who this might be right for
Kidney Disease
Myles Wolf 43
Not applicableUnknownNCT01154842
What this trial is testing

Fibroblast Growth Factor-23 (FGF-23) is Independently Associated With Left Ventricular Mass Index (LVMI) and Myocardial Performance Index (MPI) in Haemodialysis Patients

Who this might be right for
Fibroblast
Diskapi Teaching and Research Hospital 128
Testing effectiveness (Phase 2)Study completedNCT02163577
What this trial is testing

Study of KRN23 (Burosumab), a Recombinant Fully Human Monoclonal Antibody Against Fibroblast Growth Factor 23 (FGF23), in Pediatric Subjects With X-linked Hypophosphatemia (XLH)

Who this might be right for
X-linked Hypophosphatemia
Kyowa Kirin, Inc. 52
Not applicableLooking for participantsNCT06202027
What this trial is testing

Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean Patients

Who this might be right for
FGF23-related Hypophosphataemic Rickets and Osteomalacia
Kyowa Kirin Korea Co., Ltd. 100
Not applicableUnknownNCT01660308
What this trial is testing

Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalacia

Who this might be right for
Hypophosphatemia
National Taiwan University Hospital 40
Large-scale testing (Phase 3)Study completedNCT01220843
What this trial is testing

FGF23 Reduction : Efficacy of a New Phosphate Binder in CHronic Kidney Disease

Who this might be right for
Chronic Renal Failure
Centre Hospitalier Universitaire, Amiens 98
Not applicableStudy completedNCT02830464
What this trial is testing

New Biomarkers in Heart- and Renal Failure

Who this might be right for
Heart FailureKidney Failure
RWTH Aachen University 500
Not applicableStudy completedNCT01102751
What this trial is testing

Serum FGF-23 and Vitamin D Deficiency

Who this might be right for
Osteomalacia
Istanbul University
Not applicableStudy completedNCT01180946
What this trial is testing

Vitamin D Deficiency in Adolescent Girls

Who this might be right for
HealthyVitamin D Deficiency
Massachusetts General Hospital 90
Early research (Phase 1)Study completedNCT02404870
What this trial is testing

Acute Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor on Bone Metabolism in Healthy Volunteers

Who this might be right for
Healthy Volunteers
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 67
Large-scale testing (Phase 3)Study completedNCT03920072
What this trial is testing

Study of the Anti-FGF23 Antibody, Burosumab, in Adults With XLH

Who this might be right for
X-linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd 35
Not applicableUnknownNCT01317186
What this trial is testing

The Role of FGF23 and Asymmetric Dimethylarginine (ADMA) in Chronic Kidney Disease

Who this might be right for
Metabolic DiseasesChronic Kidney Disease
Ankara Education and Research Hospital 100
Not applicableStudy completedNCT03310684
What this trial is testing

Pediatric Primary Hypertension and the Renin-Angiotensin System (PHRAS)

Who this might be right for
Pediatric DisorderPediatric ObesityPrimary Hypertension
Wake Forest University Health Sciences 35
Not applicableUnknownNCT01971619
What this trial is testing

Association of Vitamin D, Parathyroid Hormone and Fibroblast Growth Factor-23 With Infarction-related Arrhythmia in Patients With Acute Myocardial Infarction

Who this might be right for
Acute Myocardial Infarction
Yonsei University 510
Not applicableUnknownNCT05258370
What this trial is testing

Fibroblast Growth Factor 23 in Chronic Respiratory Failure

Who this might be right for
Chronic Respiratory Failure
Assistance Publique - Hôpitaux de Paris 50
Not applicableStudy completedNCT05275491
What this trial is testing

Fibroblast Growth Factor 23 and Sclerostin in Relation to Calcium in COVID-19 Patients

Who this might be right for
COVID-19
Aswan University Hospital 66
Very early researchStudy completedNCT01308242
What this trial is testing

Effects of a Non-Calcium Based Phosphate Binder on FGF23 Levels in Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Milton S. Hershey Medical Center 40
Next Page